Dofetilide Conversion Time for Atrial Fibrillation
Most patients who successfully convert to sinus rhythm with dofetilide (Tikosyn) do so within 24-36 hours of starting the medication, with 87% of conversions occurring within 30 hours. 1, 2, 3
Conversion Timeline Based on Evidence
Acute Conversion Window (First 72 Hours)
The conversion rate is dose-dependent and occurs relatively quickly once therapeutic levels are achieved:
- Within 30 hours: 87% of all successful conversions occur 1, 2
- Within 24-36 hours: Most conversions happen in this timeframe 4
- Within 72 hours: The standard assessment window used in clinical trials 1
Dose-Response Relationship
The conversion rate directly correlates with the final dofetilide dose achieved 1, 2:
- 500 mcg twice daily: 30% conversion rate within 72 hours (75-85% in some cohorts) 1, 5, 6
- 250 mcg twice daily: 10% conversion rate within 72 hours (9-44% in various studies) 1, 5, 6
- 125 mcg twice daily: 6% conversion rate within 72 hours (0-20% in various studies) 1, 5, 6
Important caveat: These doses are adjusted based on creatinine clearance, so the "final dose" may be lower than 500 mcg BID in patients with renal impairment 7.
Clinical Context and Expectations
Atrial Flutter vs Atrial Fibrillation
Dofetilide is significantly more effective for atrial flutter than atrial fibrillation 1, 3:
Factors Affecting Conversion Success
Patients less likely to convert have 5:
- Larger left atrial diameter
- Longer duration of AF episode
- Lower dofetilide doses (due to renal function or QTc prolongation)
What Happens If No Conversion Occurs
If patients do not convert to normal sinus rhythm within 24 hours of initiating dofetilide therapy, electrical cardioversion should be considered 7. The FDA label explicitly states this recommendation, recognizing that pharmacologic conversion may not occur in all patients.
Monitoring Requirements During Conversion Period
All patients must be hospitalized with continuous ECG monitoring for a minimum of:
- 3 days after starting dofetilide, OR
- 12 hours after electrical/pharmacological conversion to sinus rhythm
- Whichever is greater 7
This is critical because:
- 76% of torsades de pointes cases occur within the first 3 days 7
- QTc prolongation requiring dose adjustment occurs in approximately 20% of patients 6, 10
- The risk of proarrhythmia is highest during the loading phase 7
Practical Algorithm
- Start dofetilide with dose adjusted for creatinine clearance
- Monitor continuously on telemetry
- Assess at 2-3 hours after each dose for QTc prolongation
- Expect conversion within 24-36 hours if it's going to occur
- Consider electrical cardioversion at 24 hours if still in AF and clinically indicated
- Continue monitoring for minimum 3 days regardless of conversion status
Common Pitfall
Do not assume that lack of conversion within the first few doses means treatment failure. While most conversions occur early, some patients may take the full 72-hour window. However, waiting beyond 24 hours for spontaneous conversion is not mandatory—electrical cardioversion can be performed earlier if clinically appropriate 7.